Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-09-001741
Filing Date
2009-03-13
Accepted
2009-03-13 17:04:01
Documents
11
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 MOLECULAR INSIGHT PHARMACEUTICALS, INC. b73486mie10vk.htm 10-K 1237432
2 EX-4.2 FORM OF COMMON STOCK CERTIFICATE b73486miexv4w2.htm EX-4.2 10848
3 EX-14.1 CODE OF BUSINESS CONDUCT (ADOPTED ON SEPTEMBER 16, 2008) b73486miexv14w1.htm EX-14.1 60450
4 EX-21.1 SUBSIDIARIES OF THE REGISTRANT b73486miexv21w1.htm EX-21.1 826
5 EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP b73486miexv23w1.htm EX-23.1 1918
6 EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATIONS BY THE REGISTRANT'S CHIEF EXECUT b73486miexv31w1.htm EX-31.1 8591
7 EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATIONS BY THE REGISTRANT'S CHIEF FINANC b73486miexv31w2.htm EX-31.2 8578
8 EX-32.1 SECTION 1350 CERTIFICATIONS BY THE REGISTRANT'S CHIEF EXECUTIVE OFFICER b73486miexv32w1.htm EX-32.1 2902
9 EX-32.2 SECTION 1350 CERTIFICATIONS BY THE REGISTRANT'S CHIEF FINANCIAL OFFICER b73486miexv32w2.htm EX-32.2 2878
10 GRAPHIC b73486mib7348601.gif GRAPHIC 11015
11 GRAPHIC b73486mib7348602.jpg GRAPHIC 506268
  Complete submission text file 0000950135-09-001741.txt   2048834
Mailing Address 160 SECOND STREET CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE MA 02142 617-492-5554
Molecular Insight Pharmaceuticals, Inc. (Filer) CIK: 0001340752 (see all company filings)

EIN.: 043412465 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33284 | Film No.: 09680989
SIC: 2834 Pharmaceutical Preparations